
Join to View Full Profile
- 3409 Worth St710Dallas, TX 75246 
- Phone+1 214-823-2533 
- Fax+1 214-824-8679 
Dr. Berhe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 Virginia Commonwealth University Health SystemFellowship, Infectious Disease, 2003 - 2005 Virginia Commonwealth University Health SystemFellowship, Infectious Disease, 2003 - 2005
 St Barnabas HospitalResidency, Internal Medicine, 2000 - 2003 St Barnabas HospitalResidency, Internal Medicine, 2000 - 2003
 Addis Ababa University Faculty of MedicineClass of 1993 Addis Ababa University Faculty of MedicineClass of 1993
Certifications & Licensure
 TX State Medical License 2005 - 2026 TX State Medical License 2005 - 2026
 VA State Medical License 2003 - 2006 VA State Medical License 2003 - 2006
 American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Internal Medicine
 American Board of Internal Medicine Infectious Disease American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsEfficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase...Indira Brar, Peter J Ruane, Mezgebe Berhe, Cynthia Brinson, Paul Benson
 Medicine. 2025-02-21
- 13 citationsSustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson Wurapa
 Open Forum Infectious Diseases. 2023-03-01
- 50 citationsLenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-c...Samir K Gupta, Mezgebe Berhe, Gordon Crofoot, Paul Benson, Moti Ramgopal
 The Lancet. HIV. 2023-01-01
Press Mentions
 Booster Shot May Be on Horizon for J&J Vaccine RecipientsAugust 25th, 2021 Booster Shot May Be on Horizon for J&J Vaccine RecipientsAugust 25th, 2021
 NTIDC Researchers: Pfizer Vaccine Is Safe, Ready to GoNovember 27th, 2020 NTIDC Researchers: Pfizer Vaccine Is Safe, Ready to GoNovember 27th, 2020
- More Than 2,500 Healthcare Providers Sign up to Administer Coronavirus Vaccine in TexasNovember 11th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









